Table 1.
Comparison of clinical data between the two groups.
| NG group | G group | P values | |
|---|---|---|---|
| Total cases | 341 | 164 | – |
| Fever | 252 | 137 | 0.016 |
| Low fever | 96 | 50 | 0.053a |
| Moderate fever | 119 | 64 | 0.032a |
| High fever or above | 37 | 23 | 0.036a |
| Dry cough | 141 | 59 | 0.248 |
| Fatigue | 105 | 103 | < 0.001 |
| Chest distress | 16 | 5 | 0.386 |
| Myalgia | 76 | 50 | 0.046 |
| Expectoration | 91 | 41 | 0.686 |
| Dizziness | 24 | 23 | 0.011 |
| Wheezing | 71 | 31 | 0.615 |
| Headache | 31 | 13 | 0.664 |
| Sore throat | 15 | 11 | 0.271 |
| Runny nose | 9 | 2 | 0.485b |
| OB | 16 | 12 | 0.227 |
| Systemic symptom | 132 | 118 | < 0.001 |
| Respiratory symptoms | 332 | 158 | 0.528 |
| Neurological symptoms | 46 | 33 | 0.055 |
a
The control group was non-fever patients.
b
Continuous correction chi square test used; NG group: COVID-19 patients without gastrointestinal symptoms group; G group: COVID-19 patients with gastrointestinal symptoms; Low fever: 37.3 –38.0 °C; Moderate fever:38.1–39 °C; High fever or above:>39.1 °C; OB: Faecal occult blood; Systemic symptoms include fatigue and myalgia; Respiratory symptoms include fever, dry cough, expectoration, chest distress, wheezing, sore throat and runny nose; Neurological symptoms include dizziness and headaches.